Annexon, Inc. - Common Stock, par value $0.001 (ANNX)

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
145,057,417
Number of holders
81
Total 13F shares, excl. options
47,049,561
Shares change
+774,785
Total reported value, excl. options
$243,269,266
Value change
+$3,854,655
Put/Call ratio
45.86%
Number of buys
39
Number of sells
-25
Price
$5.17

Significant Holders of Annexon, Inc. - Common Stock, par value $0.001 (ANNX) as of Q4 2022

91 filings reported holding ANNX - Annexon, Inc. - Common Stock, par value $0.001 as of Q4 2022.
Annexon, Inc. - Common Stock, par value $0.001 (ANNX) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 47,049,561 shares of 145,057,417 outstanding shares and own 32.44% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (4,886,616 shares), Alerce Investment Management, L.P. (4,408,966 shares), BVF INC/IL (3,780,694 shares), EVENTIDE ASSET MANAGEMENT, LLC (3,626,508 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3,549,975 shares), Redmile Group, LLC (3,503,190 shares), Fairmount Funds Management LLC (3,358,563 shares), VR Adviser, LLC (3,220,050 shares), FEDERATED HERMES, INC. (3,057,800 shares), and CITADEL ADVISORS LLC (1,866,783 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.